Engineer, R., Pathare, P., Bhandare, M., Krishnatry, R., Gudi, S., Ostwal, V., . . . Shrikhande, S. (2024). Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 120(2), e437. https://doi.org/10.1016/j.ijrobp.2024.07.976
Chicago Style (17th ed.) CitationEngineer, R., P. Pathare, M. Bhandare, R. Krishnatry, S. Gudi, V. Ostwal, A. Ramaswamy, and S. Shrikhande. "Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy." International Journal of Radiation Oncology, Biology, Physics 120, no. 2 (2024): e437. https://doi.org/10.1016/j.ijrobp.2024.07.976.
MLA (9th ed.) CitationEngineer, R., et al. "Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy." International Journal of Radiation Oncology, Biology, Physics, vol. 120, no. 2, 2024, p. e437, https://doi.org/10.1016/j.ijrobp.2024.07.976.